US Patent Issued to APTA Therapeutics on April 21 for "Aptamers for use in the treatment of Coronaviridae infections" (German Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,828, issued on April 21, was assigned to APTA Therapeutics GmbH (Berlin).

"Aptamers for use in the treatment of Coronaviridae infections" was invented by Annekathrin Haberland (Berlin), Johannes Muller (Berlin), Gerd Wallukat (Berlin) and Peter Gottel (Falkensee, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new aptamer molecules for use in therapy of infections caused by viruses from the Coronaviridae family, a method of preventing infection caused by viruses from the Coronaviridae family in vitro/ex vivo, a pharmaceutical composition and a kit comprising such aptamer molecules, and the use of aptamer mole...